Optimizing Palbociclib Therapy Across the Age Spectrum: Hypothetical, Illustrative Case Scenarios in HR+, HER2–Metastatic Breast Cancer

Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors in combination with endocrine therapy are a preferred treatment option for premenopausal and postmenopausal women with hormone receptor–positive (HR+), human epidermal growth factor receptor 2–negative (HER2–) metastatic breast cancer (mBC). Palboc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Adv Pract Oncol
Main Authors: Podsada, Kimberly, Ryan, Joanne C., Orbaugh, Kristi
Formato: Artigo
Idioma:Inglês
Publicado em: Harborside Press LLC 2020
Assuntos:
Grand Rounds
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7646629/
https://ncbi.nlm.nih.gov/pubmed/33575067
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6004/jadpro.2020.11.7.5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados